Fund Holdings — STEMPOINT CAPITAL LP

Total Portfolio Value:
$310.59M
Total Bought:
$123.84M
Total Sold:
$125.86M
Net Transaction:
-$2.02M
Notable People:
Michelle Avra Ross
Securities
▲▼
SharesValue
Q1 2025
▲▼
Q2 2025
▲▼
Change
▲▼
Q1 2025
▲▼
Q2 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Syndax Pharmaceuticals, Inc.(SNDX)1,598,5942,372,634+774,040$19.64M$22.22M7.15%+$2.58M
Immunovant, Inc.(IMVT)853,4721,300,860+447,388$14.59M$20.81M6.70%+$6.23M
Scholar Rock Holding Corporation(SRRK)566,212528,115-38,097$18.20M$18.71M6.02%+$502.1K
Centessa Pharmaceuticals PlcADS593,3351,265,672+672,337$8.53M$16.63M5.35%+$8.10M
Madrigal Pharmaceuticals, Inc.(MDGL)40,93652,694+11,758$13.56M$15.95M5.13%+$2.39M
Merus N V346,756266,094-80,662$14.59M$14.00M4.51%-$598.4K
Arcellx Inc
COMMON STOCK
273,774201,452-72,322$17.96M$13.27M4.27%-$4.69M
Cidara Therapeutics Inc0266,774+266,774$0$12.99M4.18%+$12.99M
Rhythm Pharmaceuticals, Inc.(RYTM)33,816176,752+142,936$1.79M$11.17M3.60%+$9.38M
Alkermes plcSHS(ALKS)192,352351,124+158,772$6.35M$10.04M3.23%+$3.69M
Denali Therapeutics Inc.(DNLI)667,078707,915+40,837$9.07M$9.90M3.19%+$834.8K
Legend Biotech CorporationADS(LEGN)0270,144+270,144$0$9.59M3.09%+$9.59M
Geron Corporation(GERN)960,3076,649,244+5,688,937$1.53M$9.38M3.02%+$7.85M
Zai Lab LimitedADR(ZLAB)26,421250,438+224,017$954.9K$8.76M2.82%+$7.80M
Mineralys Therapeutics, Inc.(MLYS)0631,586+631,586$0$8.55M2.75%+$8.55M
uniQure N.V.SHS(QURE)731,039572,615-158,424$7.75M$7.98M2.57%+$233.2K
Roivant Sciences Ltd.SHS(ROIV)2,578,860601,781-1,977,079$26.02M$6.78M2.18%-$19.24M
Akero Therapeutics Inc156,185116,779-39,406$6.32M$6.23M2.01%-$91.0K
Insmed Incorporated(INSM)87,05961,578-25,481$6.64M$6.20M2.00%-$444.5K
Surrozen, Inc.(SRZN)240,826686,539+445,713$2.81M$6.14M1.98%+$3.33M
Wave Life Sciences, Inc.SHS(WVE)89,833900,338+810,505$725.9K$5.85M1.88%+$5.13M
LENZ Therapeutics, Inc.(LENZ)0183,912+183,912$0$5.39M1.74%+$5.39M
Nuvalent Inc190,40159,828-130,573$13.50M$4.56M1.47%-$8.94M
Kalvista Pharmaceuticals Inc386,837386,790-47$4.46M$4.37M1.41%-$91.4K
Vistagen Therapeutics, Inc.(VTGN)2,366,5542,413,254+46,700$5.11M$4.12M1.33%-$994.3K
Apogee Therapeutics Inc084,466+84,466$0$3.67M1.18%+$3.67M
IDEAYA Biosciences, Inc.(IDYA)66,999165,885+98,886$1.10M$3.49M1.12%+$2.39M
Protara Therapeutics, Inc.(TARA)1,190,5791,143,677-46,902$5.07M$3.47M1.12%-$1.61M
Helix Acquisition Corp IiCL A200,900315,812+114,912$2.27M$3.29M1.06%+$1.02M
EyePoint, Inc.(EYPT)0329,254+329,254$0$3.10M1.00%+$3.10M
Arcutis Biotherapeutics, Inc.(ARQT)440,073205,672-234,401$6.88M$2.88M0.93%-$4.00M
Rezolute, Inc.(RZLT)0644,654+644,654$0$2.88M0.93%+$2.88M
Taysha Gene Therapies, Inc.(TSHA)01,203,941+1,203,941$0$2.78M0.90%+$2.78M
Newamsterdam Pharma Company
ORDINARY SHARES
104,585152,652+48,067$2.14M$2.76M0.89%+$623.7K
Biohaven Ltd.(BHVN)250,564174,754-75,810$6.02M$2.47M0.79%-$3.56M
Regeneron Pharmaceuticals, Inc.(REGN)04,672+4,672$0$2.45M0.79%+$2.45M
BridgeBio Pharma, Inc.(BBIO)208,43754,630-153,807$7.21M$2.36M0.76%-$4.85M
Janux Therapeutics, Inc.(JANX)342,06289,933-252,129$9.24M$2.08M0.67%-$7.16M
ORIC Pharmaceuticals, Inc.(ORIC)0200,785+200,785$0$2.04M0.66%+$2.04M
MBX Biosciences, Inc.(MBX)96,615141,021+44,406$713.0K$1.61M0.52%+$896.0K
Perceptive Cap Solutions CorCL A
CL A ORD SHS
150,000150,0000$1.54M$1.59M0.51%+$48.0K
Praxis Precision Medicines, Inc.(PRAX)032,255+32,255$0$1.36M0.44%+$1.36M
GH Research PLC(GHRS)0100,826+100,826$0$1.23M0.40%+$1.23M
Tango Therapeutics, Inc.(TNGX)0208,800+208,800$0$1.07M0.34%+$1.07M
Protagonist Therapeutics Inc49,24116,770-32,471$2.38M$926.8K0.30%-$1.45M
Tectonic Therapeutic, Inc.(TECX)040,000+40,000$0$794.8K0.26%+$794.8K
ADC Therapeutics SASHS(ADCT)0283,286+283,286$0$759.2K0.24%+$759.2K
Verona Pharma PlcADS07,407+7,407$0$700.6K0.23%+$700.6K
ABIVAX Société AnonymeADS(ABVX)087,748+87,748$0$671.3K0.22%+$671.3K
Mind Medicine Mindmed Inc090,852+90,852$0$589.6K0.19%+$589.6K
Amicus Therapeutics Inc
COM
268,9190-268,919$2.19M$0—-$2.19M
Arbutus Biopharma Corporation(ABUS)467,8820-467,882$1.63M$0—-$1.63M
Ascendis Pharma A/SADR(ASND)14,7320-14,732$2.30M$0—-$2.30M
Bicara Therapeutics Inc47,0780-47,078$613.4K$0—-$613.4K
Blueprint Medicines Corp61,9270-61,927$5.48M$0—-$5.48M
CG Oncology, Inc.(CGON)289,8230-289,823$7.10M$0—-$7.10M
Cytokinetics, Incorporated(CYTK)149,6480-149,648$6.01M$0—-$6.01M
Dyne Therapeutics, Inc.(DYN)84,4300-84,430$883.1K$0—-$883.1K
Edgewise Therapeutics, Inc.(EWTX)180,2550-180,255$3.97M$0—-$3.97M
Enliven Therapeutics Inc120,4300-120,430$2.37M$0—-$2.37M
InflaRx N.V.(IFRX)725,0190-725,019$739.5K$0—-$739.5K
Neurocrine Biosciences, Inc.(NBIX)21,0520-21,052$2.33M$0—-$2.33M
Ocular Therapeutix, Inc.(OCUL)124,5230-124,523$912.8K$0—-$912.8K
Revolution Medicines, Inc.(RVMD)318,7820-318,782$11.27M$0—-$11.27M
Sionna Therapeutics, Inc.(SION)60,0000-60,000$627.6K$0—-$627.6K
Soleno Therapeutics Inc11,1550-11,155$797.0K$0—-$797.0K
Solid Biosciences Inc198,1500-198,150$733.2K$0—-$733.2K
Springworks Therapeutics Inc159,3050-159,305$7.03M$0—-$7.03M
Spyre Therapeutics, Inc.(SYRE)136,1390-136,139$2.20M$0—-$2.20M
Xenon Pharmaceuticals Inc.(XENE)274,6330-274,633$9.21M$0—-$9.21M
Page 1 of 1
STEMPOINT CAPITAL LP — 13F Holdings — Q2 2025 | TickerTrail